NCT03347617 2025-09-09Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With GlioblastomaOHSU Knight Cancer InstitutePhase 2 Terminated52 enrolled 15 charts
NCT02070705 2025-07-31DCE MRI in Patients With Pancreatic CancerOHSU Knight Cancer InstitutePhase NA Terminated77 enrolled